Filing Flows › Mesa Laboratories (MLAB) › Guidance & outlook
Mesa Laboratories (MLAB) guidance and outlook
Mesa Laboratories (MLAB) gave its guidance on Oct 13, 2026: Stock-based compensation $300K–$400K for .
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Stock-based compensation | $300K–$400K | new |
From the earnings release filed Oct 13, 2026 (8-K on EDGAR).
Mesa Laboratories' latest quarter
Mesa Laboratories, Q1 FY27: revenue $60.1M (+1% year over year), operating margin 11.7%, net earnings $2.8M, operating cash flow $14.7M. The chart follows the revenue to costs, profit and cash.
Questions
Did Mesa Laboratories raise or lower its guidance?
Mesa Laboratories (MLAB) gave its guidance on Oct 13, 2026: Stock-based compensation $300K–$400K for .
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.